• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宿主胆固醇影响利什曼原虫中固醇生物合成抑制剂的活性。

Host cholesterol influences the activity of sterol biosynthesis inhibitors in Leishmania amazonensis.

机构信息

Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Bioquímica de Tripanossomatídeos, Rio de Janeiro, RJ, Brasil.

Fundação Oswaldo Cruz-Fiocruz, Instituto Oswaldo Cruz, Laboratório de Patologia, Rio de Janeiro, RJ, Brasil.

出版信息

Mem Inst Oswaldo Cruz. 2022 Apr 4;117:e220407. doi: 10.1590/0074-02760220407. eCollection 2022.

DOI:10.1590/0074-02760220407
PMID:35384972
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8979231/
Abstract

A significant percentage of exogenous cholesterol was found in promastigotes and amastigotes of all studied species of Leishmania, suggesting a biological role for this molecule. Previous studies have shown that promastigotes of Leishmania uptake more low-density lipoprotein (LDL) particles under pharmacological pressure and are more susceptible to ergosterol inhibition in the absence of exogenous sources of cholesterol. This work shows that the host's LDL is available to intracellular amastigotes and that the absence of exogenous cholesterol enhances the potency of sterol biosynthesis inhibitors in infected macrophages. A complete understanding of cholesterol transport to the parasitophorous vacuole can guide the development of a new drug class to be used in combination with sterol biosynthesis inhibitors for the treatment of leishmaniases.

摘要

在外源胆固醇中发现有很大一部分存在于所有研究的利什曼原虫的前鞭毛体和无鞭毛体中,这表明该分子具有生物学作用。先前的研究表明,在药理学压力下,利什曼原虫摄取更多的低密度脂蛋白(LDL)颗粒,并且在没有外源胆固醇的情况下更容易受到麦角固醇抑制。这项工作表明,宿主的 LDL 可用于细胞内无鞭毛体,并且缺乏外源胆固醇会增强感染巨噬细胞中固醇生物合成抑制剂的效力。对外源胆固醇转运到滋养体空泡的全面了解可以指导开发新的药物类别,与固醇生物合成抑制剂联合用于治疗利什曼病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d67/8979231/70b293d410e0/1678-8060-mioc-117-e220407-gf3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d67/8979231/109e84133aed/1678-8060-mioc-117-e220407-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d67/8979231/b7cd56c4afe2/1678-8060-mioc-117-e220407-gf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d67/8979231/70b293d410e0/1678-8060-mioc-117-e220407-gf3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d67/8979231/109e84133aed/1678-8060-mioc-117-e220407-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d67/8979231/b7cd56c4afe2/1678-8060-mioc-117-e220407-gf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d67/8979231/70b293d410e0/1678-8060-mioc-117-e220407-gf3.jpg

相似文献

1
Host cholesterol influences the activity of sterol biosynthesis inhibitors in Leishmania amazonensis.宿主胆固醇影响利什曼原虫中固醇生物合成抑制剂的活性。
Mem Inst Oswaldo Cruz. 2022 Apr 4;117:e220407. doi: 10.1590/0074-02760220407. eCollection 2022.
2
H-2M molecules, like MHC class II molecules, are targeted to parasitophorous vacuoles of Leishmania-infected macrophages and internalized by amastigotes of L. amazonensis and L. mexicana.H-2M分子与MHC II类分子一样,定位于感染利什曼原虫的巨噬细胞的寄生泡,并被亚马逊利什曼原虫和墨西哥利什曼原虫的无鞭毛体内化。
J Cell Sci. 1999 Aug;112 ( Pt 15):2559-70. doi: 10.1242/jcs.112.15.2559.
3
Imipramine alters the sterol profile in Leishmania amazonensis and increases its sensitivity to miconazole.丙咪嗪改变亚马逊利什曼原虫的甾醇谱并增加其对咪康唑的敏感性。
Parasit Vectors. 2016 Mar 31;9:183. doi: 10.1186/s13071-016-1467-8.
4
Fusion between Leishmania amazonensis and Leishmania major parasitophorous vacuoles: live imaging of coinfected macrophages.亚马逊利什曼原虫和内脏利什曼原虫寄生泡融合:共感染巨噬细胞的实时成像。
PLoS Negl Trop Dis. 2010 Dec 7;4(12):e905. doi: 10.1371/journal.pntd.0000905.
5
The pharmacological inhibition of sterol biosynthesis in Leishmania is counteracted by enhancement of LDL endocytosis.固醇生物合成的药理学抑制作用在利什曼原虫中被 LDL 内吞作用的增强所拮抗。
Acta Trop. 2011 Aug;119(2-3):194-8. doi: 10.1016/j.actatropica.2011.05.001. Epub 2011 May 13.
6
Changes to cholesterol trafficking in macrophages by Leishmania parasites infection.利什曼原虫感染对巨噬细胞中胆固醇转运的影响。
Microbiologyopen. 2017 Aug;6(4). doi: 10.1002/mbo3.469. Epub 2017 Mar 27.
7
In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species.一种氟喹诺酮衍生物对婴儿利什曼原虫和亚马逊利什曼原虫的体外和体内抗利什曼活性。
Acta Trop. 2019 Mar;191:29-37. doi: 10.1016/j.actatropica.2018.12.036. Epub 2018 Dec 23.
8
Tamoxifen is effective against Leishmania and induces a rapid alkalinization of parasitophorous vacuoles harbouring Leishmania (Leishmania) amazonensis amastigotes.他莫昔芬对利什曼原虫有效,并能使含有亚马逊利什曼原虫(Leishmania)无鞭毛体的寄生泡迅速碱化。
J Antimicrob Chemother. 2007 Sep;60(3):526-34. doi: 10.1093/jac/dkm219. Epub 2007 Jun 21.
9
Intracellular Leishmania amazonensis amastigotes internalize and degrade MHC class II molecules of their host cells.细胞内的亚马逊利什曼原虫无鞭毛体内化并降解其宿主细胞的MHC II类分子。
J Cell Sci. 1995 Oct;108 ( Pt 10):3219-31. doi: 10.1242/jcs.108.10.3219.
10
Potent In Vitro Antiproliferative Synergism of Combinations of Ergosterol Biosynthesis Inhibitors against Leishmania amazonensis.麦角固醇生物合成抑制剂组合对亚马逊利什曼原虫的高效体外抗增殖协同作用
Antimicrob Agents Chemother. 2015 Oct;59(10):6402-18. doi: 10.1128/AAC.01150-15. Epub 2015 Aug 3.

引用本文的文献

1
Itaconate: A Nexus Metabolite Fueling Survival Through Lipid Metabolism Modulation.衣康酸:一种通过调节脂质代谢促进生存的关键代谢物
Microorganisms. 2025 Feb 27;13(3):531. doi: 10.3390/microorganisms13030531.
2
Deciphering the mechanism of action of VP343, an antileishmanial drug candidate, in .解析抗利什曼原虫候选药物VP343的作用机制
iScience. 2023 Oct 5;26(11):108144. doi: 10.1016/j.isci.2023.108144. eCollection 2023 Nov 17.
3
Fatty Acid Composition and Metabolism in Parasite Species: Potential Biomarkers or Drug Targets for Leishmaniasis?

本文引用的文献

1
Phytosterol Profiles, Genomes and Enzymes - An Overview.植物甾醇概况、基因组与酶——概述
Front Plant Sci. 2021 May 19;12:665206. doi: 10.3389/fpls.2021.665206. eCollection 2021.
2
Leishmaniasis: where are we and where are we heading?利什曼病:我们在哪里,我们要往哪里去?
Parasitol Res. 2021 May;120(5):1541-1554. doi: 10.1007/s00436-021-07139-2. Epub 2021 Apr 7.
3
A Review of Leishmaniasis: Current Knowledge and Future Directions.利什曼病综述:当前认知与未来方向
寄生虫物种中的脂肪酸组成和代谢:利什曼病的潜在生物标志物或药物靶点?
Int J Mol Sci. 2023 Feb 28;24(5):4702. doi: 10.3390/ijms24054702.
Curr Trop Med Rep. 2021;8(2):121-132. doi: 10.1007/s40475-021-00232-7. Epub 2021 Mar 17.
4
Effect of Itraconazole-Ezetimibe-Miltefosine Ternary Therapy in Murine Visceral Leishmaniasis.伊曲康唑-依泽替米贝-米替福新三联疗法对小鼠内脏利什曼病的影响
Antimicrob Agents Chemother. 2023 May 1;65(5). doi: 10.1128/AAC.02676-20. Epub 2021 Feb 22.
5
Regulation of Ergosterol Biosynthesis in .麦角固醇生物合成的调控。
Genes (Basel). 2020 Jul 15;11(7):795. doi: 10.3390/genes11070795.
6
Leishmaniasis.利什曼病。
Lancet. 2018 Sep 15;392(10151):951-970. doi: 10.1016/S0140-6736(18)31204-2. Epub 2018 Aug 17.
7
Changes to cholesterol trafficking in macrophages by Leishmania parasites infection.利什曼原虫感染对巨噬细胞中胆固醇转运的影响。
Microbiologyopen. 2017 Aug;6(4). doi: 10.1002/mbo3.469. Epub 2017 Mar 27.
8
Exploring Leishmania donovani 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) as a potential drug target by biochemical, biophysical and inhibition studies.通过生化、生物物理和抑制研究探索杜氏利什曼原虫 3-羟基-3-甲基戊二酰辅酶 A 还原酶(HMGR)作为潜在的药物靶点。
Microb Pathog. 2014 Jan;66:14-23. doi: 10.1016/j.micpath.2013.11.001. Epub 2013 Nov 14.
9
Leishmania major Self-Limited Infection Increases Blood Cholesterol and Promotes Atherosclerosis Development.硕大利什曼原虫自限性感染会增加血液胆固醇并促进动脉粥样硬化发展。
Cholesterol. 2013;2013:754580. doi: 10.1155/2013/754580. Epub 2013 Apr 28.
10
Leishmania donovani targets Dicer1 to downregulate miR-122, lower serum cholesterol, and facilitate murine liver infection.杜氏利什曼原虫靶向 Dicer1 下调 miR-122,降低血清胆固醇,并促进小鼠肝脏感染。
Cell Host Microbe. 2013 Mar 13;13(3):277-88. doi: 10.1016/j.chom.2013.02.005.